A breakthrough in the world of medicine has been announced by scientists from MIT. Utilizing artificial intelligence, they have developed two new types of antibiotics, a feat not achieved in many years. This development is poised to usher in a second golden age of antibiotic discovery. The significance of this cannot be overstated, as these new antibiotics have the potential to combat infections resistant to current medications. These resistant infections are linked to approximately 5 million fatalities annually. The rise of these ‘superbugs’ is due to the consistent use of the same antibiotics over the years. However, with the use of generative AI algorithms, researchers have designed and evaluated over 36 million potential compounds for antimicrobial properties. This has led to the successful discovery of unique antibacterial molecules, unlike any currently in the market. While more refinement and testing are required, it is hoped that these new antibiotics will be available in the next few years, marking a significant medical milestone.